Trade Summary

1 month ago, Stratton John G, serving as Dir at ABBOTT LABORATORIES (ABT), purchased 2,000 shares at $86.82 per share, for a total transaction value of $173,640.00. Following this transaction, Stratton John G now holds 23,319 shares of ABT.

This purchase represents a 9.38% increase in Stratton John G's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 7, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 5:08 PM ET, 42 days after the trade was made.

ABBOTT LABORATORIES operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.